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Abstract Herpes Simplex Virus type I (HSV-1) latently in-
fects peripheral nervous system (PNS) sensory neurons, and
its reactivation leads to recurring cold sores. The reactivated
HSV-1 can travel retrograde from the PNS into the central
nervous system (CNS) and is known to be causative of Herpes
Simplex viral encephalitis. HSV-1 infection in the PNS is well
documented, but little is known on the fate of HSV-1 once it
enters the CNS. In the murine model, HSV-1 genome persists
in the CNS once infected through an ocular route. To gain
more details of HSV-1 infection in the CNS, we characterized
HSV-1 infection of the tree shrew (Tupaia belangeri
chinensis) brain following ocular inoculation. Here, we report
that HSV-1 enters the tree shrew brain following ocular inoc-
ulation and HSV-1 transcripts, ICP0, ICP4, and LAT can be
detected at 5 days post-infection (p.i.), peaking at 10 days p.i.
After 2 weeks, ICP4 and ICP0 transcripts are reduced to a basal
level, but the LAT intron region continues to be expressed.
Live virus could be recovered from the olfactory bulb and
brain stem tissue. Viral proteins could be detected using anti-
HSV-1 antibodies and anti-ICP4 antibody, during the acute
stage but not beyond. In situ hybridization could detect LAT
during acute infection in most brain regions and in olfactory
bulb and brain stem tissue well beyond the acute stage. Using a
homogenate from these tissues’ post-acute infection, we did
not recover live HSV-1 virus, supporting a latent infection,
but using a modified explant cocultivation technique, we were
able to recover reactivated virus from these tissues, suggesting
that the HSV-1 virus latently infects the tree shrew CNS. Com-
pared to mouse, the CNS acute infection of the tree shrew is
delayed and the olfactory bulb contains most latent virus. Dur-
ing the acute stage, a portion of the infected tree shrews exhibit
symptoms similar to human viral encephalitis. These findings,
together with the fact that tree shrews are closely related to
primates, provided a valuable alternative model to study
HSV-1 infection and pathogenesis in the CNS.
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Introduction
Following eye infection, Herpes simplex virus type 1(HSV-1)
is transferred by fast axonal transport to the nuclei of trigem-
inal ganglia sensory neurons, in which it forms a latent infec-
tion. Reactivation of this latent infection leads to productive
viral infection at the peripheral site of inoculation, which can
cause skin lesions and herpes simplex keratitis (HSK). The
reactivated virus can also spread to the central nervous system
(CNS), where it may lead to Herpes Simplex Virus encepha-
litis (HSE), the most common cause of sporadic and often fatal
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Studies suggest that HSE pathogenesis is related to the reac-
tivation of latent virus in the brain tissue, rather than the spread
of reactivated virus from ganglia (Sekizawa and Openshaw
1984; Jones et al. 2005; Chen et al. 2006). With an incidence
of 1 in 200,000 individuals per year, HSE is associated with
70 % mortality in untreated patients and 30 % mortality in
treated patients, leaving most affected individuals permanent
neurological damages (Kimberlin 2003; Chayavichitsilp et al.
2009). HSV-1 genomes can be detected in the human brain
(Fraser et al. 1981; Lin et al. 1997), and both primary and
recurrent infections may induce encephalitis (Gilden et al.
2007), with the latter accounting for 70 % of encephalitis
cases (Chaudhuri and Kennedy 2002). However, the mecha-
nism of HSE pathogenesis is not well understood. Clearly,
HSV establishes latency in sensory ganglia of the peripheral
nervous system (PNS) (Spivack and Fraser 1987; Spivack
et al. 1995; Webre et al. 2012; Roizman and Whitley 2013),
but whether HSVexists as latent or permanently silenced viral
genome in the CNS has not been fully investigated (Cabrera
et al. 1980; Deatly et al. 1988). Mouse and rabbit CNS HSV-1
infections have been reported (Knotts et al. 1973; Rock and
Fraser 1983; Smith et al. 2000). Recent evidence demonstrat-
ing that HSV-1 could be reactivated using a modified explant
co cultivation method suggests that HSV-1 can form latent
infections from which it can be reactivated in the CNS (Chen
et al. 2006).
Although rodent models have been used extensively to
study HSV infection, they differ significantly from human
infection and pathogenesis due to their distance from primates
in evolution and their differences in immunity. In addition,
significant differences also exist between murine and rabbit
latency infection models (Nicoll et al. 2012; Webre et al.
2012), raising a need for an alternative model that is both
economic and more closely mimics the human HSV infection.
The tree shrew is a small squirrel-like animal indigenous to
southwest Asia and is more closely related to primates than do
rodents at both genomic and transcriptomic levels (Fan et al.
2014; Xu et al. 2013a; Zheng et al. 2014). Anatomically, a tree
shrew brain is more similar to a primate’s (Wang et al. 2013),
supporting the development of tree shrews as alternative hu-
man disease models, including the study of vision, social
stress, and neurological/psychiatric diseases, to name a few
(Ohl et al. 1998; Guo et al. 2013; He et al. 2014).
HSV has been known to infect and establish latent infec-
tions in tree shrews since the 1970s (Darai et al. 1978; Xu et al.
2013b). Several studies have been done using an intraperito-
neal infection (Rosenwolff et al. 1989). In this study, we have
further characterized HSV-1 infection of the tree shrew CNS
following ocular inoculation. During the acute stage of infec-
tion, live virus could be first detected on 5 days post-infection
(p.i.), peaked on 10 days p.i., and disappeared after 2 weeks
p.i. Coincident with this, viral transcripts ICP0, ICP4, and
LAT intron, detected by qRT-PCR, also started to appear on
5 days p.i., peaked between 8 and 10 days p.i., and returned to
a basal level with the exception of LAT intron, which remain
at a high level of expression for the entire course of our ob-
servation (2 months). We also detected HSV-1 antigens by
immunohistochemistry (IHC) using anti-HSV-1 antibodies
and ICP4 protein immunofluorescence (IF) using anti ICP4
antibody. The expression of LATafter the acute stage infection
led us to hypothesize a latent infection by HSV-1. In situ
hybridizations analysis using a stable LAT intron confirmed
that LAT is indeed expressed in brain stem and olfactory bulb
well beyond acute stage. Using explant cocultivation experi-
ment, we were able to recover reactivated virus from brain
stem and olfactory bulb. Taken together, these results demon-
strated that HSV-1 latently infects the CNS of tree shrew.
Materials and methods
Animals
Adult tree shrews (Tupaia belangeri chinensis), 6-month-old
females, were obtained from the animal breeding facility at the
Kunming Institute of Zoology (KIZ). BALB/cmice were used
as experimental controls and were raised in the SPF facility in
KIZ.
Ethics statement
All tree shrew and mouse experiments were performed ac-
cording to the procedures and policies of BThe Guide for the
Care and Use of Laboratory Animals^ (published by the NA-
TIONAL ACADEMY PRESS Washington, D.C.1996). The
study protocol of ocular HSV-1 infection was reviewed and
approved by the Institutional Animal Care and Use Commit-
tee of Kunming Institute of Zoology, Chinese Academy of
Sciences. The identification number is SYDW20121201001.
Handling of animals
Animals were anesthetized with an intramuscular injection
with ketamine (100 mg/kg), and infection achieved by
dropping 106 PFU of HSV-1 McKrae virus inoculum on each
eye without ocular scarification. Mock-infected animals were
anesthetized, and a PBS solution of equal volume was
dropped on each eye. Animals were returned to cages follow-
ing recovery from the anesthesia and monitored every 12 h
during the first week, and daily during the second week fol-
lowing infection, for signs of disease.
Viruses The pathogenic HSV-1 strain McKrae was used in
our experiments. All virus was grown on vero cells and titered
on RS1 cells.
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Cell lines and antibodies All cells were obtained from Con-
servation Genetics CAS Kunming Cell Bank and were grown
in T75 flask (NEST, 708001) with Dulbecco’s Modified Eagle
Medium (Gibco, 12800–017) and 5 %(v/v) fetal bovine serum
(Pufei, 1101–500). These cells were used to prepare the virus-
es and determine virus titer. Rabbit skin cells (RS1) cultured in
same conditions were used for brain explant cocultivation
experiments. The ICP4 monoclonal antibody was obtained
fromGerdMaul’s laboratory at theWistar Institute (Showalter
et al. 1981). HSV-1 polyclonal antibodies were from Ameri-
can Qualex Antibodies (RR1190P).
HSV-1 titer in mouse and tree shrew brains during acute
infection
To assay for the presence of infectious virus in mice or tree
shrew’s brain during the acute stage of infection, parts of the
brain were homogenized and the supernatant incubated with
RS1 cells to detect infectious virus. Viral titering was done
according to Chayavichitsilp et al. (2009). We dissected and
homogenized the brain from infected animals at mock-infected,
3, 5, 8, 10, and 13 days post-infection, followed by coculturing
the supernatant with RS1 cells to detect live HSV-1 virus.
HSV-1 viral genomic DNA load in latently infected mouse
and tree shrew brain tissue determined by Quantitative
real-time PCR
Mice or tree shrews brain stems and olfactory bulbs were
harvested from infected animals 30 days post-infection. The
genomic DNA was extracted by Genomic DNA purification
kit (DP304-03, Tiangen), and the amounts of viral (UL30,
DNA polymerase) and cellular (18 s) DNA in samples were
quantified by real-time PCR. The quantification standards of
viral genomes were prepared by reconstituting known
amounts (copies) of HSV-1 genomes with homogenates of
brain stems or olfactory bulbs from uninfected mice or tree
shrews. Known amounts of tissue DNA (in μg) prepared from
mouse or tree shrew brain stems and olfactory bulbs were used
as the quantification standards for cellular DNA. The number
of copies of viral genomes was normalized to the amount of
cellular DNA in the sample and expressed as viral genome
copies per microgram of tissue DNA.
Total RNA extraction from tissue
At 4 weeks post-infection (p.i.), animals were euthanized, and
the brains dissected and prepared for qRT-PCR. Brain tissue
frozen with liquid nitrogen was ground to a powder. Fifty
milligrams of powder was placed into a 1.5-ml centrifuge tube
with the addition of 1 ml Trizol. After mixing and standing for
5 min at room temperature (RT), 0.2 ml chloroformwas added
with vibrating for 15 s. After standing 2 min at RT, the mix
was centrifuged at 4 °C, 12,000g×15 min. Isopropanol
(0.5 ml) was added to the supernatant followed by gently
mixing, standing for 10 min at RT, and centrifuging at 4 °C
and 12000 g for 10 min. The supernatant was discarded, and
1 ml 75 % ethanol was added to gently wash the precipitate.
This was then centrifuged at 4 °C, 12000 g×10 min, and the
supernatant was discarded. After drying, the precipitate was
dissolved in DEPC-treated H2O. After reading the 260/
280 nm and 260 nm absorption reading, the sample was store
frozen at −80 °C.
qRT-PCR detection of HSV-1 transcripts in infected
mouse and tree shrew brain
Reverse transcription from total RNA extraction to cDNAwas
done using PrimeScript™ RT reagent Kit with gDNA Eraser
(Takara, Cat. No. RR047A). Quantitative PCR was done in a
7900HT instrument fromApplied Biosystem using a FastStart
Universal SYBR Green Master (Rox kit, Roche, Cat. No.
04913850001). The reference genome for HSV-1 coordinates
is from HSV-1 17+, GeneBank: JN555585.
Immunohistochemistry detection of HSV-1 proteins
Tree shrew brains were embedded in paraffin and sectioned at
a thickness of 5 μm on a microtome (Leica, RM2245). Slides
were treated at 60 °C for 30–60 min, then deparaffinized in
xylene and a gradient concentration of ethanol. Deparaffinized
slides were rinsed with water and antigen retrieved in boiling
citric acid buffer (PH=6.0) for 24 min, which was boiled by
microwave. After natural cooling, slides were washed suffi-
ciently with water, immersed in 3 % H2O2 for 10 min, and
permeabilized with 0.5 % TritonX-100 at RT for 10 min.
Blocked in 5 % BSA at RT for 30 min, then incubated with
diluted primary antibody (Rabbit anti HSV1, Cat. RR1190P,
American Qualex Antibodies) at 4 °C, incubated overnight
and subsequently diluted secondary antibody added (anti-rab-
bit IgG HRP-labeled Antibody, Cat #7074S, Cell Signaling
Technology) at room temperature for 60 min. After develop-
ment with DAB (Cat. DAB-0031) for 3 min, slides were
washed in water and did counterstainwith hematoxylin. Slides
were dehydrated in a gradient concentration of ethanol and
dehydrated with xylene, for 3–5 min each. Finally, slides were
mounted with neutral balsam and the signal detected with a
Nikon, 80i fluorescent microscope.
Immunofluorescence detection of ICP4 proteins
Tree shrew brains were embedded in paraffin and sectioned
5 μm thick on a microtome (Leica, RM2245). Slides were
heated at 60 °C for 30–60 min, then deparaffinized in xylene
and a concentration gradient of ethanol. Deparaffinized slides
were rinsed with water and antigen renatured by boiling
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(microwave) in sodium citrate buffer at PH=6.0 for 24 min,
which was boiled by microwave. After natural cooling, slides
were washed sufficiently with water (weak water flow 5 min,
3 times), and the tissue permeabilized with 0.5 % TritonX-100
at RT for 10 min. Slides were blocked in 5 % BSA at RT for
30 min, then incubated with diluted (1:1000) primary anti-
body (monoclonal antibody against ICP4 obtained from Dr.
Gerd Maul’s laboratory) at 4 °C overnight and subsequently
added diluted secondary antibody (1:1000, Alexa Fluor 594
Goat Anti-Mouse IgG (H+L) from Life Technologies) at RT
for 60 min. To visualize the cell nucleus, all samples were
double stained with Hoechst. Finally, slides were mounted
with mounting medium and signals detected under the micro-
scope (Nikon, 80i).
In situ hybridization
RNA probes corresponding to the HSV-1 Latency Associated
Transcript (LAT) intron region (probe position: 120,384–121,
418 nt) were labeled with DigU (DIG RNA Labeling Mix,
Cat.11 277 073 910, Roche). Dissected tree shrew’s brains
were embedded in paraffin and sectioned 5 μm thick on a
microtome (Leica, RM2245). Sections were deparaffinized
in xylene and a gradient concentration of ethanol. RNA in situ
hybridization was performed as followed. Briefly, slides were
fixed in 4 % PFA at room temperature before protease K
treatment and re-fixing in 4 % PFA. After fixation, slides were
acetylated by 0.25 % acetic anhydride (sigma, 320102)/0.1 M
triethanolamine (sigma, 90279). The slides were then treated
in pre-hybridization solution (10 mM Tris, 600 mM NaCl,
1 mM EDTA, 0.25 % SDS, 1×Denhardt’s, 50 % formamide,
300ug/ml Yeast tRNA) for 2 h at 60 °C and subsequently
hybridized in hybridization buffer (pre-hybridization plus
339.5 μl 25 % dextran sulfate and add probe to a final con-
centration of 1–2 μg/ml hybridization solution) with LAT
probe over night at 60 °C. After a serial wash of SSC buffers
of different concentrations (1×SSC/50 % formamide, 2×
SSC, and 0.2×SSC buffer) at 65 °C, the Anti-Digoxigenin-
AP Fab Fragments antibody (Roche, Cat. 11 093 274 910) is
incubating in MABT buffer over night at 4 °C. Then, slides
were developed in alkaline phosphatase buffer (100 mM Tirs
PH 9.5, 50 mMMgCl2, 100 mMNaCl, 0.1 % Tween 20) with
BCIP/NBT (Roche, Cat.11383221001, Cat.11383213001,
100 mg/ml NBT 3.375 μl, and 3.5μl 50 mg/ml BCIP in
1 ml alkaline phosphatase) and hematoxylin & eosin
counterstaining. Finally, the sections were inspected using a
Nikon 80i fluorescent microscope to determine presence of
LAT.
HSV-1 reactivation detection by explant cocultivation test
We used method described by Chen et al. (2006). Briefly, at
4 weeks post-infection (p.i.), animals were euthanized and
brains were dissected. Brain tissues were cut into small section
and incubated in serum-free DMEM containing 0.08% trypsin,
0.013 % collagenase type I-A(Sigma), 20 mM HEPES, L-glu-
tamine, HCO3, penicillin, streptomycin, and amphotericin B.
After constant agitation for 40min at 37 °C, the suspension was
centrifuged at 300×g for 10 min at 4 °C, and the pellet was
resuspended in DMEM containing 10 % fetal bovine serum,
2 mM L-glutamine, 0.075 % HCO3, 200 U/ml penicillin,
200 ug/ml streptomycin, and 0.25 ug/ml amphotericin B
(Fungizone). Then, the suspension was transferred to confluent
monolayers of RS1 cells (1×105 cells/well in six-well plates).
The explant cultures were incubated at 37 °C in 5 % CO2 with
change of fresh medium every 3 days. Cultures were observed
daily for the development of cytopathic effect (CPE) in RS1
cells. If no CPEwas detected after 2 weeks, the brain tissue was
scored negative for reactivation. The samples that showed neg-
ative CPE were further incubated for up to a month to ensure
that there was indeed no CPE developing. If virus-induced CPE
was noted, the cell media was removed and saved for DNA
extraction and testing (PCR/sequence) for HSV-1.
To distinguish between persistent infections and latency,
brain tissues were also homogenized, centrifuged at slow
speed, and the supernatant incubated with RS1 cells for over
10 days to detect infectious virus. A total of 18 mouse olfac-
tory bulbs, 18 mouse brain stems, 18 tree shrew olfactory
bulbs, and 18 tree shrew brain stems were homogenized to
assay for the presence of infectious virus by plaque assay on
RS1 cells as previously described (Tullo et al. 1982).
Results
Survival rate of mice and tree shrews after ocular HSV-1
infection
To determine the most humane method to infect tree shrews,
we compared the lethality rate of HSV-1 17+ strain, applied
with ocular scarification (a method typically used in rodent
studies), and the more virulent McKrae strain, applied in the
absence of ocular scarification, to infect both tree shrew and
mouse. Tree shrews were anesthetized with ketamine, follow-
ed by ocular scarification, then 1×106 PFU of HSV-1 17+
virus in PBS solution was applied to each eye. The HSV-1
McKrae virus inoculum was dropped directly onto the eyes
of animals without corneal scarification. Through the same
method, we infected mice, with 4×104 PFU of HSV-1 17+ or
McKrae virus to each eye. Eyes and other sites weremonitored
daily for disease signs, and the mortality was recorded (Fig. 1).
Infected tree shrews showed ruffling of fur, anorexia,
weight loss, lethargy, and lack of activity during the acute
stage of infection, which typically started at 5 days p.i.
and lasted until the end of 2 weeks p.i.. The infected tree
shrews also developed eye disease and cornea infection,
296 J. Neurovirol. (2016) 22:293–306
which occurred from 5 days p.i. and lasted until approx-
imately 4 weeks (the eye disease will be discussed in a
separate study). About 10 % of the tree shrews showed
severe nervous system disease symptoms similar to hu-
man encephalitis, such as ataxia, astasia, torticollis,
looking up at the sky (or star gazing), and other abnormal
behaviors. These symptoms suggest that HSV-1-infected
the CNS of tree shrew during acute stage. Most of the
animals displaying these symptoms perished within the
first 2 weeks of the experiment (Fig. 1).
During acute infection, the clinical symptoms of tree
shrews were milder than that of mice, while infected an-
imals without ocular scarification (both tree shrew and
mice) displayed milder disease symptoms than those with
corneal scarification, even though the McKrea strain is
known to be more virulent. Mortality of infected tree
shrews occurred at around 6 and 7 days p.i., while infect-
ed mice began to die at 4 days p.i. The survival rate of
HSV-1 17+ infected mice with ocular scarification was
50 %, while the survival rate of HSV-1 McKrae-infected
mice without ocular scarification was 63 %. When tree
shrews were analyzed, the survival rate of HSV-1 17+
infected tree shrews with ocular scarification was 67 %,
but the survival rate of HSV-1 McKrae-infected tree
shrews, in the absence of ocular scarification, reached
up to 80 % (Fig. 1). Overall, the HSV-1 McKrae-infected
animal showed better survival rate than HSV-1 17+ infect-
ed animals, suggesting that the scarification technique
permitted a stronger infection than the use of a more vir-
ulent strain. For this reason, we chose HSV-1 McKrae
strain to infect tree shrews and mice in our subsequent
studies.
HSV-1 virus was detectable in tree shrew brain
during the acute stage of infection
To confirm that a productive infection existed in HSV-1-
infected tree shrew brains, we dissected and homogenized
the brains from mock and infected animals at 3, 5, 8, 10, and
13 days p.i. Following a low-speed spin to pellet the cell
debris, the supernatant was co-cultured with RS1 cells to de-
tect infectious HSV-1 virus. At 20 h after incubation with
supernatant from brains of infected mice and tree shrews, we
could readily observe CPE due to HSV-1 lytic infection in
RS1 cells. We measured the titer of the viral yield in mouse
and tree shrew brain homogenate supernatants from groups of
4 animals at each time point (mock-infected, 3, 5, 8, 10, and
13 days p.i., see Fig. 2). The amount of infectious HSV-1 virus
in brains of infected mice was similar to previously published
data, peaking at 5 days p.i. and becoming weaker at 8 days p.i.
(Yao et al. 2014). Infectious virus was detected in the infected
tree shrew brain tissue at 5, 8, 10, and 13 days p.i., with the
highest level of virus titer at 10 days p.i.. Unlike mouse, no
CPE was seen in RS1 cells cultured with supernatant from
3 days p.i. tree shrew brain, even after extended incubation
over 10 days. This result suggests that there was a delay in the
acute infection of tree shrew brain compared to mouse brain
following eye infection (Fig. 2).
qRT-PCR detection of HSV-1 transcripts in acutely
infected tree shrew brain
To further investigate the HSV-1 acute infection in tree shrew
brain, we monitored the expression of ICP0, ICP4, and LAT
intron in tree shrew CNS tissue by qRT-PCR. For comparison,
we used specific primers towards these genes to measure the
respective RNA levels by qRT-PCR in HSV-1McKrae-infect-
ed BALB/c mice. We detected high levels of transcripts from
Fig. 2 Virus titering of infected mouse and tree shrew brain. Dissected
and homogenized brain supernatants from infected animals were titrated
at indicated times p.i. Results are expressed as the log10 mean PFU/
100 mg brain tissue for each group. Data were collected from at least
two independent experiments, and the number of animals assayed at each
time point (mock-infected, 3, 5, 8, 10, and 13 days p.i.) was 4. Blue
rhombus represents viral titer in mouse brain; orange square represents
viral titer in tree shrew brain
Fig. 1 Survival rate of mice and tree shrews after HSV-1 infection. HSV-
1 17+ andMcKrae virus strains were inoculated into mice and tree shrews
cornea, respectively. Animals were monitored daily for signs of disease
and mortality. Blue rhombus represents HSV-1 17+ infected mice,
survival rate (50 %); blue triangle represents HSV-1 McKrae infected
mice, survival rate (63 %); orange square represented HSV-1 17+ infect-
ed tree shrews, survival rate (67 %); orange circles represented HSV-1
McKrae infected tree shrews, survival rate (80 %). n=30 for each group
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Fig. 3 qRT-PCR detection of HSV-1 transcripts in infected animal brain.
HSV-1 strain McKrae infected mice and tree shrews were anesthetized,
euthanized, and dissected for brain tissue. RNA from these samples was
extracted for qRT-PCR analyses. aMouse brain from various days post-
infection, qRT-PCR of ICP0 (black line), ICP4 (red line), and LAT (blue
line) results were plotted as fold-change relative to 18S. b Similar to a, but
the Y-axis was replaced with ΔCT. c Tree shrew brain viral transcripts
were detected by qRT-PCR, and the results were represented as fold-
change over β-actin. d Similar to c, except the Y-axis was replaced with
ΔCT. e Primers used in the qRT-PCR detection of viral transcripts
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all three genes at 3 days p.i. and even higher levels at 5 days
p.i., while after 2 weeks (13 days p.i.), these transcripts
dropped to a low basal level (Fig. 3a, b). This pattern suggests
that these mice were going through acute infection. Compared
to mice, HSV-1 McKrae-infected tree shrew CNS tissue
expressed ICP0, ICP4, and LAT transcripts at similar levels
during acute infection, but they peaked at a later time of
10 days p.i. After 2 weeks, the expression of ICP0, ICP4
transcripts decreased to low levels; however, LAT intron con-
tinued to be expressed at higher levels (Fig. 3c, d). In mice
after 20 days p.i., we did not detect significantly higher LAT
expression by qRT-PCR, but we did detect LAT by in situ
hybridization well beyond the acute stage.
HSV-1 antigens were detectable using
immunohistochemistry in tree shrew brain
To further characterize the tree shrew CNS infection, we
performed immunohistochemistry to detect HSV-1 anti-
gens during the course of infection. MRI 3D reconstruc-
tions of the tree shrew brains in dorsal, ventral, and left
side view with dissected tissues circled in red are shown
in Fig. 4 (Zheng et al. 2014). HSV-positive signals were
detected from olfactory bulbs and brainstem of McKrae-
infected mice at 5 days p.i. (arrows in Fig. 5b, e), while
in Mock-infected samples, no positive signals were ob-
served (Fig. 5a, d). The mouse brain stem and olfactory
bulb are two brain regions where HSV-1 has previously
been detected (Chen et al. 2006). Compared with mice,
HSV-1 antigen signals in infected tree shrew brains ap-
pear from 8 days p.i. and become more significant at
10 days p.i. Strong and robust signals were detected in
the olfactory bulbs and brainstem, but we also observed
HSV-1 antigens in cerebral cortex, hippocampus, and
thalamus at 8 and 10 days p.i. (see Fig. 5h, k, n, q,
and t, arrows labels positive signals). No HSV-1 antigen
signals were seen in any brains regions of the mock-
infected animals (Fig. 5g, j, m, p, and s). There was no
specific region where the virus appeared first, suggest-
ing that once it entered the brain, the virus spread
quickly through neuronal connections. However, based
on the abundance of HSV-1 antigen signals and the
route of infection, the brain stem and olfactory bulb
may be the portals where the virus enters the CNS.
After the acute stage of infection, the CNS of the in-
fected mice and tree shrews showed no IHC signals
using HSV-1 antibodies (Fig. 5c, f, i, l, o, r, and u).
Our mouse CNS results are consistent with observations
by others (Rock and Fraser 1983; Smith et al. 2000).
These results indicated that there is no persistent
Fig. 4 3-D view of the tree shrew
brain. (adapted from Basic
Biology and Disease Models of
Tree Shrews (Zheng et al. 2014).
Copy right release obtained from
Kunming Institute of Zoology,
Chinese Academy of Sciences). a
Tree shrew brain MRI 3-D
reconstruction dorsal view. b Tree
shrew brain MRI 3-D
reconstruction ventral view. c
Tree shrew brain MRI 3-D
reconstruction left-side view. d
Different regions of the brain are
marked. Dissected regions of the
brain for experiments described in
this study are circled in red.
Dashed circled areas (HPF)
marked areas that are beneath the
surface of the brain
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infection after the acute stage in the CNS tissue of
either mice or tree shrews.
Immunofluorescence detected HSV-1 ICP4 proteins
in tree shrew brain
The qRT-PCR and immunohistochemistry results (Figs. 3
and 5) suggest that HSV-1 underwent a productive
infection and therefore should be expressing immediate
early gene proteins. To confirm this, we performed immu-
nofluorescence with ICP4 monoclonal antibodies to detect
the ICP4 protein. Figure 6a–e shows mock-infected and
McKrae-infected mouse brain during the acute phase. We
could clearly see ICP4 staining appear at 5 days post-
infection in the nucleus of neuronal cells (yellow arrows
in Fig. 6c). In mock-infected mouse brain, or in 3, 8, and
Fig. 5 Immunohistochemical
detection of HSV-1 antigens in
mice and tree shrew brains. Mice
and tree shrew were corneal
inoculated with the McKrae strain
of HSV-1 without ocular
scarification. CNS tissues were
dissected, paraffin embedded,
sectioned, and processed for
immunohistochemistry with
polyclonal anti-HSV-1
antibodies. a and dMock-
infected mouse control, arrows
point to neurons and non-
neuronal cells in brain. b and e
Mouse olfactory bulb and
brainstem 5 days p.i. with HSV-1
McKrae, arrows point to infected
neurons positive for HSV-1
antigens. c and fMouse olfactory
bulb and brainstem 33 days p.i.
with HSV-1 McKrae, no positive
signal for HSV-1 antigens. g Tree
shrew (TS) olfactory bulb mock-
infected control, arrows point to
neuronal cells. h and i TS
olfactory bulb 8 and 33 days p.i.
with HSV-1 Mckrae. j TS Brain
Stem mock-infected control. k
and l TS brain stem 8 and 33 days
p.i. with HSV-1 McKrae. m TS
cerebral cortex mock-infected
control. n and o TS cerebral
cortex 8 and 33 days p.i. with
HSV-1 McKrae. p TS Thalamus
mock-infected control. q and r TS
thalamus 10 and 33 days p.i. with
HSV-1 McKrae. s TS
hippocampus mock-infected
control. t and u TS hippocampus
10 and 33 days p.i. with HSV-1
McKrae, arrows show neurons
positive for HSV-1 antigens. At
mock-infected and 33 days p.i.
with HSV-1 McKrae, TS
olfactory bulbs, brain stem,
cerebral cortex, thalamus and
hippocampus showed no HSV-1-
positive signal
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10 days post-infection mouse brain, no ICP4 signal was
seen (white arrows point to neuronal nucleus in Fig. 6a, b,
d, and e). Figure 6f shows no ICP4 signal in mouse brain
at 33 days p.i. In infected tree shrew brains, robust posi-
tive ICP4 protein signals were first seen at 8 days p.i.
(yellow arrows in Fig. 6j) and remain robust at 10 days
p.i. (Fig. 6k). In mock-infected tree shrew brain, or in 3,
33 days post-infection tree shrew brain, no ICP4 signal
was seen (white arrows point to neuronal nucleus in
Fig. 6g, h, and l). Unlike mouse, there was no ICP4 signal
prior to 5 day p.i. in tree shrews (Fig. 6i). The delayed
appearance of ICP4 compared to mouse is consistent with
the qRT-PCR experiment and IHC staining described
above (Figs. 3 and 5), suggesting that the virus may be
taking a longer path or different route entering the CNS.
In situ hybridization detected LAT transcription
in HSV-1-infected tree shrew brain
As LAT is the only transcript consistently expressed during
HSV latency from a large number of studies (Bloom 2004),
its expression in the tree shrew brain is indicative that HSV-
1 may be latently infecting the tree shrew CNS. To defini-
tively confirm the existence and distribution of LAT tran-
script, we used RNA probes corresponding to the stable
HSV-1 LAT intron region (probe position: 120,384–121,
418 nt) and performed in situ hybridization as described in
the infected tree shrew brain. As controls, mock-infected tree
shrew CNS sections were subject to in situ hybridization,
and no positive signal could be seen in any brain regions
of these animals (Fig. 7a, d, g, j, and m). In the infected
Fig. 6 Immunofluorescent staining of ICP4 protein in mouse and tree
shrew brain. At 3, 5, 8, 10, and 33 days p.i. with HSV-1 strain McKrae,
mock and infected mice and tree shrews were euthanized, brains
dissected, paraffin embedded and sectioned on a microtome before
staining with an immunofluorescent ICP4 antibody. a Mock-infected
mouse brain control, no positive signal detected, white arrows indicate
neuronal cells. b HSV-1 McKrae infected mice at 3 days post-infection
showed no ICP4 signal. cAt 5 days p.i., ICP4 signal was readily detected
in large neuronal cells in the brain. Yellow arrows point to ICP4-positive
signal. dAt 8 days p.i., ICP4 staining showed no signal. eAt 10 days p.i.,
ICP4 stained showed no signal. fAt 33 days p.i., ICP4 stained showed no
signal. g Mock-infected tree shrew brain control, white arrows point to
neuronal cells. h Infected tree shrews brain at 3 days p.i. shows no ICP4
signal. i Infected tree shrew brain at 5 days p.i. shows no ICP4 signal. j
HSV-1 McKrea infected tree shrew brain section at 8 day p.i., showing
positive ICP4 signal. k At 10 days p.i., more robust positive ICP4 signals
were seen. l At 33 days p.i., ICP4 stained was no signal
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group, LAT signal could be detected in olfactory bulbs, ce-
rebral cortex, hippocampus, thalamus, and brainstem of in-
fected tree shrews as early as 8 days p.i. (see arrows in
Fig. 7b, e, h, k, and n). At the same brain region of 10 days
p.i., more LAT signals were detected (arrows in Fig. 7c, f, i,
l, and o).
We next determined LAT expression after the acute stage
and detected LAT signals mostly in the tree shrew olfactory
bulbs and brainstem at 20, 33, and 46 days p.i. (arrows in
Fig. 8a–f). In the cerebral cortex, hippocampus and thalamus
at 20, 33, and 46 days p.i., no detectable LAT transcription
was seen (8G-8O). We noted that these LAT signals are nu-
clear, consistent with its distribution in human and other ani-
mal models of HSV latency, and its role as a noncoding RNA
(Umbach et al. 2008). Since the probe was made against the
intron region of LAT, the strength of the signal also supports
high stability of the intron in tree shrews, as previously report-
ed in mice (Farrell et al. 1991). Taken together, the in situ
hybridization results discussed here, and qRT-PCR study in
Fig. 3 strongly suggests that HSV-1 establishes a latent infec-
tion in the tree shrew brain.
Tree Shrews brains are latently infected as determined
by the explant cocultivation test
The data described above suggests that HSV-1 latently infects
the tree shrew CNS. To support this hypothesis, an explant co-
cultivation test was performed as described by Chen et al.
(2006). The explant cocultivation test using HSV-1 latently
infected trigeminal ganglia has been widely used for many
years to demonstrate viral reactivation from latency in PNS
tissue (Stevens and Cook 1971). However, this test has failed
Fig. 7 Detection of LAT signals
in HSV-1 acute infected tree
shrew brain by in situ
hybridization. Sections of tree
shrew brain, embedded in
paraffin, were used to perform
RNA in situ hybridization, as
described in the BMethods^ using
RNA probes corresponding to the
LAT intron region. Each panel
shows representative staining
from groups of between 3 and 6
animals. aMock-infected tree
shrew olfactory bulb (OLF)
control showed no signal. b and c
By days 8 and 10 p.i., LAT signal
was readily detectable in tree
shrew OLF (red arrow). dMock-
infected tree shrew cerebral
cortex (CTX) control showed no
signal. e and f By days 8 and 10
p.i., LAT signal was detectable in
tree shrew CTX (red arrow). g
Mock-infected tree shrew
hippocampal formation (HPF)
control showed no signal. h and i
At days 8 and 10 p.i., LAT signal
was detectable in tree shrew HPF
(red arrow). jMock infected tree
shrew thalamus (TH) control
showed no signal. k and lBy days
8 and 10 p.i., LAT signal was
detectable in tree shrew TH (red
arrow). mMock-infected tree
shrew brain stem (BS) control
showed no signal. n and o By
days 8 and 10 p.i., LATsignal was
detectable in tree shrew BS (red
arrow)
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on several occasions to show reactivation from CNS tissue of
mice. Two possibilities could account this difference, either
the HSV-1 genome was permanently silenced or the higher
lipid content of CNS tissue block the reactivated virus from
entering culture medium to infect the RS1 cells. Many years
ago, Knotts et al. reported explants cocultivation of HSV from
latent rabbit brain (Knotts et al. 1973), and more recently,
Chen SH et al. described a modified method, which included
a step to dissociate neurons and demonstrated that HSV-1
indeed could be reactivated from the infected brain, thus
confirming that HSV-1 could latently infect the CNS (Chen
et al. 2006). Using this modified explant cocultivation meth-
od, infectious HSV-1 virus was recovered from olfactory
bulbs and brainstem of latently infected mice and tree shrews.
In the tree shrew, we recovered reactivated virus from olfac-
tory bulbs of 22 % of the tested animals, while in mouse the
cumulative rate of recovery was 11 % (Fig. 9a). The appear-
ance of CPE, a sign of reactivated virus infecting a monolayer-
cultured cells, was 7 days for tree shrew olfactory bulbs and
10 days for the mouse counterpart. Both of these times are
significantly delayed compared trigeminal ganglia explant co-
cultivations. In the brain stems, the rate of reactivation was
reversed, with mouse showing a much higher rate of reactiva-
tion at 67 %, while tree shrew brainstem at 11 %. The first
reactivation in tree shrew is also sooner than that of mouse,
with tree shrew at 8 days, and mouse at 8–12 days (Fig. 9b).
These results strongly support the hypothesis that HSV-1 in-
deed latently infects the tree shrew CNS.
Fig. 8 Detection of LAT signals
in HSV-1 latent infected tree
shrew brain by in situ
hybridization. LAT intron signals
were detected in olfactory bulb
(OLF), brain stem (BS), cerebral
cortex (CTX), hippocampal
formation (HPF) and thalamus
(TH) at 20, 33 and 46 days p.i. a–
cBy days 20, 33, and 46 p.i., LAT
signal was detectable in tree
shrew OLF (red arrow). d–f and
in tree shrew BS (red arrow). g–i
By days 20, 33, and 46 p.i., no
LAT signal was detectable in tree
shrew CTX. j–l Tree shrew HPF
m–o or in tree shrew TH
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To distinguish between persistent and latent infection, brain
tissue from each animal was dissected, homogenized, centri-
fuged at slow speed, and the supernatant incubated with RS1
cells for over 10 days. No infectious virus was recovered from
the brain supernatants of tested animals, although the viral
DNA is clearly present in both the mouse and tree shrew brain
tissues (Fig. 9c). These results are consistent with the IHC data
(Fig. 5), immunofluorescent staining using ICP4 antibody
(Fig. 6) and previous studies (Cabrera et al. 1980; Yao et al.
2012). They confirm that a persistent infection was not present
in the neural tissues used for our reactivation studys, and thus,
the HSV-1 virus was latent in both mice and tree shrews.
Discussion
Here, we described infection of the tree shrew brain fol-
lowing cornea inoculation with the pathogenic HSV-1
McKrae strain. During the acute phase of infection, the
most severely infected tree shrews exhibited many symp-
toms similar to viral encephalitis in humans, manifested by
anorexia, lethargy, ataxia, torticollis, and abnormal whirl
before perishing during the acute stage. Homogenates of
brain tissue from infected tree shrew and mouse contain
infectious virus indicating an acute infectious stage that
started shortly after inoculation and lasted approximately
2 weeks. qRT-PCR analyses detected viral IE genes ICP0,
ICP4 transcripts, and immunohistochemistry using anti
HSV-1 antibodies and immunofluorescence with anti ICP4
antibody confirmed the existence of productive infection in
both mouse and tree shrew brains. After the acute stage of
infection, the LAT transcript continues to be expressed in
the absence of ICP4, especially in tree shrew brain, sug-
gesting that the virus is latent. Homogenizing the brain
tissue and testing the supernatants for virus on tissue cul-
ture cells confirmed this. Using a modified explant cocul-
tivation method (Chen et al. 2006), we found that virus
could indeed be reactivated from these latently infected
Fig. 9 HSV-1 reactivation from
infected mice and tree shrews
brain. Mice and tree shrews were
infected with HSV-1 strain
McKrae at the indicated dose via
eye cornea inoculation. At
30 days post-infection (dpi),
neural tissues were harvested and
assayed for reactivation of latent
virus as described in the
BMethods.^ Data were collected
from at least two independent
experiments. The number of
animals assayed in each group
was 18. a Olfactory bulb, blue
rhombus represented mouse
(11 % reactivation). Orange
square represented tree shrew
olfactory bulb (22 %
reactivation). b Brain stem, blue
triangle represented mouse (67 %
reactivation); orange circles
represented tree shrew (11 %
reactivation). cViral DNA load in
latent mouse and tree shrew
olfactory bulbs and brain stems.
Brain stems and olfactory bulbs of
tree shrews or mice infected with
HSV-1 McKrae for 30 days were
dissected to quantify the numbers
of copies of viral genomes per μg
of tissue DNA. Each point on the
scattergrams represents an
individual sample, and the
horizontal lines represent the
mean values for each group.
*P<0.05; Mann–Whitney U test
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brain tissues. However, the frequency was lower and the
appearance of CPE delayed compared to latently infected
mouse and tree shrew TGs.
Route of viral entry into the CNS
Following eye infection, HSV is transmitted via fast axional
transport to neuron cell bodies in the trigeminal ganglion,
where it can form latent infections and be transmitted retro-
grade to the nuclei of the trigeminal ganglion in the brain stem.
It has been speculated that, following eye inoculation, HSV-1
can enter the nasal passage via the canaliculus and lacrimal sac
from which it is transferred to the nasolacrimal duct and into
the back of the nose. This is the route tears take when draining
from the eye. This virus can then have direct access to CNS
neurons in the back of the nose and enter the olfactory bulb
(Tullo et al. 1982; Spivack and Fraser 1987; Deatly et al.
1988). Virus may also enter the CNS following reactivation
of latent virus in the PNS and subsequent retrograde transport
to the nuclei of the trigeminal nerve in the brain stem. In the
infection models we used, we observed high levels of infec-
tious virus and viral proteins from both olfactory bulb and the
brain stem. This observation suggests that both routes of CNS
entry exist in tree shrew and mouse. However, comparing the
explant cocultivation results from brain stem and olfactory
bulb between mouse and tree shrew, the tree shrew appeared
to have a higher frequency of reactivation from the olfactory
bulb, while mouse seemed to have a higher frequency from
brain stem tissue. This difference suggests that the route of
entry into the CNS in the tree shrew is predominately through
the olfactory bulb, while in mouse HSV-1 more likely enters
the CNS through the brain stem. The delay of viral appearance
in the CNS in the tree shrew may also support this hypothesis,
or may be due to the difference in distances the virus has to
transverse in the two different sized animals.
HSV-1 latency in the tree shrew brain
HSV-1 latency is well documented in infected ganglia
(Spivack and Fraser 1987; Spivack et al. 1995; Webre et al.
2012; Roizman andWhitley 2013), but whether it also latently
infects the CNS, as determined by reactivation from CNS
tissue, is an important question that has seen data both
supporting and not supporting reactivation. This question is
key to our understanding of the pathogenesis of Herpes Sim-
plex encephalitis. Explant cocultivation of latently infected
ganglia with monolayers of susceptible cells has been widely
adopted by the field as a test for reactivation from latency
(Block et al. 1990). Such a method has not been widely suc-
cessful to show HSV-1 reactivation from infected CNS tissue
and is one of the main reasons for the notion that HSV-1
cannot be reactivated fromCNS tissue and may be permanent-
ly silenced in the CNS (Cabrera et al. 1980). Recently, Chen
et al. have demonstrated that HSV-1-infected mouse CNS tis-
sue can produce infectious virus using a modified explant
cocultivation method (Chen et al. 2006). Using this method,
we were able to recover live infectious HSV-1 virus from
infected tree shrew brain tissue. These findings support the
hypothesis that the HSV-1 genome is not permanently si-
lenced and can be reactivated under appropriate conditions.
Based on the expression of LAT, the absence of detectable
virus and viral proteins of infected brain tissue beyond the
acute stage of infection, and the ability to reactivate from
explant, we conclude that HSV-1 established latent infection
in tree shrew CNS. Whether HSV-1 latency in the CNS is the
same as the latency in trigeminal ganglia, and whether latent
HSV-1 can be reactivated under physiological conditions re-
mains to be demonstrated. Clearly, while humans commonly
show recurrent reactivations at the periphery, they rarely show
signs of encephalitis.
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